Search Results - Ashley M. Hopkins

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials

    Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials by Michael J. Sorich, Andrew Rowland, Christos S. Karapetis, Ashley M. Hopkins

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift

    Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift by Ashley M. Hopkins, Jessica M. Logan, Ganessan Kichenadasse, Michael J. Sorich

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

    Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab by Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab

    Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab by Ashley M. Hopkins, Ganessan Kichenadasse, Elizabeth Garrett–Mayer, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

    Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer by Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab

    Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab by Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease

    Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease by Lauren A. Newman, Zivile Useckaite, Jillian G. Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy

    The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy by Sarah Badaoui, Adel Shahnam, Ross A. McKinnon, Ahmad Y. Abuhelwa, Michael J. Sorich, Ashley M. Hopkins

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control Trials

    Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control Trials by Ashley M. Hopkins, Sarah Badaoui, Ganessan Kichenadasse, Christos S. Karapetis, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

    Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers by Ashley M. Hopkins, Andrew Rowland, Ganessan Kichenadasse, Michael D. Wiese, Howard Gurney, Ross A. McKinnon, Christos S. Karapetis, Michael J. Sorich

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150

    Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150 by Ashley M. Hopkins, Ganessan Kichenadasse, Ross A. McKinnon, Ahmad Y. Abuhelwa, Jessica M. Logan, Sarah Badaoui, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis

    Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis by Dorsa Maher, Emily Reeve, Ashley M. Hopkins, Jiun Ming Tan, Mahsa Tantiongco, Nagham Ailabouni, Richard Woodman, Lisa K. Stamp, David Bursill, Susanna Proudman, Michael D. Wiese

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data

    The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data by Natansh D. Modi, Eugene Tan, Andrew Rowland, Bogda Koczwara, Ahmad Y. Abuhelwa, Ganessan Kichenadasse, Ross A. McKinnon, Michael D. Wiese, Michael J. Sorich, Ashley M. Hopkins

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling Approach

    Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling Approach by Michael J. Sorich, Arkady T. Manning‐Bennett, Lee X. Li, Adel Shahnam, Ganessan Kichenadasse, Christos S. Karapetis, Ahmad Y. Abuhelwa, Ross A. McKinnon, Andrew Rowland, Ashley M. Hopkins

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis

    Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis by Bradley D. Menz, Nicole M. Kuderer, Stephen Bacchi, Natansh D. Modi, Benjamin Chin‐Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnès Vitry, Ross A. McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models

    Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models by Bradley D. Menz, Natansh D. Modi, Ahmad Y. Abuhelwa, Warit Ruanglertboon, Agnès Vitry, Yuan Gao, Lee X. Li, Rakchha Chhetri, Benjamin Chu, Stephen Bacchi, Ganessan Kichenadasse, Adel Shahnam, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system

    Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system by Jingying Tang, Giang T. Lam, Robert D. Brooks, Mark A. Miles, Zivile Useckaite, I. R. Johnson, Benjamin S.‐Y. Ung, Carmela Martini, Litsa Karageorgos, Shane M. Hickey, Stavros Selemidis, Ashley M. Hopkins, Andrew Rowland, Ryash Vather, John O’Leary, Doug A. Brooks, Maria C. Caruso, Jessica M. Logan

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial

    Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority... by Janet Dunn, Peter Donnelly, Nada Elbeltagi, Andrea Marshall, Ashley M. Hopkins, Alastair M. Thompson, Riccardo A. Audisio, Sarah E. Pinder, David Cameron, Sue M. Hartup, Lesley Turner, Annie Young, Helen M. Higgins, Eila Watson, Sophie Gasson, Peter Barrett‐Lee, Claire Hulme, Bethany Shinkins, Peter Hall, Andrew Evans

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: